We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Baker Hughes
BKR
$56.8B
| $5.57M | 0.15% |
122,382
+73,961
| +153% | +$3.51M |
|
102
CoreCivic
CXW
$3.1B
| $5.51M | 0.14% |
+288,212
| New | +$5.28M |
|
103
Brown-Forman Class B
BF.B
$12B
| $5.49M | 0.14% |
+210,755
| New | +$5.93M |
|
104
Gates Industrial Corporation Ltd.
GTES
$6.81B
| $5.49M | 0.14% |
255,562
+214,965
| +530% | +$4.96M |
|
105
Trimble
TRMB
$12.3B
| $5.46M | 0.14% |
69,707
+37,135
| +114% | +$2.96M |
|
106
Leidos
LDOS
$14.1B
| $5.41M | 0.14% |
+29,987
| New | +$5.68M |
|
107
Omnicom Group
OMC
$22.7B
| $5.39M | 0.14% |
66,733
+60,536
| +977% | +$4.63M |
|
108
Unum
UNM
$13.8B
| $5.39M | 0.14% |
69,498
+65,746
| +1,752% | +$5.03M |
|
109
IQVIA
IQV
$34.7B
| $5.38M | 0.14% |
+23,856
| New | +$5.19M |
|
110
Boston Scientific
BSX
$65.8B
| $5.37M | 0.14% |
56,285
+6,347
| +13% | +$622K |
|
111
Essential Utilities
WTRG
$11.2B
| $5.37M | 0.14% |
+139,884
| New | +$5.5M |
|
112
DuPont de Nemours
DD
$18.6B
| $5.31M | 0.14% |
44,038
+36,846
| +512% | +$4.15M |
|
113
Sony
SONY
$123B
| $5.31M | 0.14% |
+207,259
| New | +$5.82M |
|
114
RPM International
RPM
$13.7B
| $5.3M | 0.14% |
50,968
+44,345
| +670% | +$4.8M |
|
115
Nu Holdings
NU
$68.1B
| $5.2M | 0.14% |
310,574
+126,540
| +69% | +$2.03M |
|
116
Dell
DELL
$283B
| $5.17M | 0.14% |
41,105
+13,033
| +46% | +$1.84M |
|
117
BorgWarner
BWA
$13.2B
| $5.17M | 0.14% |
+114,683
| New | +$5.02M |
|
118
iShares Russell 1000 ETF
IWB
$47.7B
| $5.16M | 0.14% |
13,816
+762
| +6% | +$282K |
|
119
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
| $5.14M | 0.14% |
+20,542
| New | +$5.16M |
|
120
Vanguard S&P 500 ETF
VOO
$968B
| $5.11M | 0.13% |
+8,146
| New | +$5.06M |
|
121
Autoliv
ALV
$8.6B
| $5.08M | 0.13% |
42,776
+34,874
| +441% | +$4.16M |
|
122
Revvity
RVTY
$12.3B
| $5.07M | 0.13% |
52,368
+37,335
| +248% | +$3.58M |
|
123
Blue Owl Capital
OWL
$6.39B
| $5.05M | 0.13% |
+337,968
| New | +$5.28M |
|
124
Aaon
AAON
$8.41B
| $5.03M | 0.13% |
+65,938
| New | +$6.09M |
|
125
iShares S&P 500 Value ETF
IVE
$48.9B
| $5.02M | 0.13% |
+23,691
| New | +$4.97M |
|
Similar funds
HW
AAM
RWM
SAM
FWI
PP
VH
TSW
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.